Cosmo Pharmaceuticals N.V.
CMOPF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2 | $77 | $76 | -$6 |
| Dep. & Amort. | $6 | $5 | $7 | $7 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1 | $1 | $1 | $3 |
| Change in WC | -$5 | -$3 | $3 | $1 |
| Other Non-Cash | $1 | -$18 | $12 | $14 |
| Operating Cash Flow | $1 | $63 | $99 | $18 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3 | -$3 | -$1 | -$2 |
| Net Acquisitions | $0 | $0 | $0 | $1 |
| Inv. Purchases | $0 | -$157 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $34 | $0 | $0 |
| Other Inv. Act. | $45 | $87 | -$79 | $109 |
| Investing Cash Flow | $42 | -$39 | -$80 | $108 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$1 | $0 | $0 |
| Stock Issued | $0 | $3 | $0 | $0 |
| Stock Repurch. | -$8 | -$3 | -$2 | -$1 |
| Dividends Paid | -$25 | -$32 | $0 | -$4 |
| Other Fin. Act. | -$2 | -$2 | -$3 | -$179 |
| Financing Cash Flow | -$34 | -$35 | -$5 | -$184 |
| Forex Effect | -$2 | $1 | -$0 | $0 |
| Net Chg. in Cash | $51 | $42 | $2 | -$34 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $0 | $2 | $0 | $119 |
| End Cash | $51 | $44 | $2 | -$34 |
| Free Cash Flow | -$2 | $59 | $98 | $16 |